The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 18, 2007

Filed:

May. 09, 2005
Applicants:

Pia M. Challita-eid, Encino, CA (US);

Rene S. Hubert, Los Angeles, CA (US);

Steven Chappell Mitchell, Gurnee, IL (US);

Arthur B. Raitano, Los Angeles, CA (US);

Mary Faris, Los Angeles, CA (US);

Daniel E. H. Afar, Pacific Palisades, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Inventors:

Pia M. Challita-Eid, Encino, CA (US);

Rene S. Hubert, Los Angeles, CA (US);

Steven Chappell Mitchell, Gurnee, IL (US);

Arthur B. Raitano, Los Angeles, CA (US);

Mary Faris, Los Angeles, CA (US);

Daniel E. H. Afar, Pacific Palisades, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Assignee:

Agensys, Inc., Santa Monica, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/06 (2006.01); C12N 1/20 (2006.01); C12N 15/00 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel gene (designated 121P1F1) and its encoded protein are described. While 121P1F1 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including prostate, bladder, kidney, brain, bone, cervical, uterine, ovarian, breast, pancreatic, stomach, colon, rectal, leukocytic, liver and lung cancers. Consequently, 121P1F1 provides a diagnostic and/or therapeutic target for cancers, and the 121P1F1 gene or fragment thereof, or its encoded protein or a fragment thereof used to elicit an immune response.


Find Patent Forward Citations

Loading…